2. Федеральный регистр больных с сахарным диабетом. Доступ: http://sd.diaregistry.ru/ (дата обращения – 01.11.2023). [Federal Register of Patients with Diabetes mellitus. URL: http://sd.diaregistry.ru/ (date of access – 01.11.2023) (In Russ.)].

3. International Diabetes Federation. IDF diabetes atlas. 10th ed. Brussels, Belgium. 2021. URL:https://www.diabetesatlas.org (date of access – 01.11.2023).

4. Дедов И.И., Шестакова М.В., Галстян Г.Р. Распространенность сахарного диабета 2 типа у взрослого населения России (исследование NATION). Сахарный диабет. 2016; 19(2): 104–112. [Dedov I.I., Shestakova M.V., Galstyan G.R. Prevalence of type 2 diabetes mellitus in the adult population of Russia (NATION study). Sakharnyy diabet = Diabetes Mellitus. 2016; 19(2): 104–112 (In Russ.)]. https://dx.doi.org/10.14341/DM2004116-17. EDN: WBAQHX.

5. Мамедов М.Н., Сушкова Л Т., Исаков Р.В. с соавт. Оценка нарушений липидного обмена и гипергликемии в открытой популяции 30–69 лет: результаты многоцентрового исследования. Кардиоваскулярная терапия и профилактика. 2023; 22(6): 46–53. [Mamedov M.N., Sushkova L.T., Isakov R.V. et al. Evaluation of lipid disorders and hyperglycemia in an open population aged 30–69 years: Results of a multicenter study. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2023; 22(6): 46–53 (In Russ.)]. https://dx.doi.org/10.15829/1728-8800-2023-3597. EDN: SGIMKS.

6. Francois M.E., Oetscet K.M. Prediabetes: Challenges, novel solutions, and future directions. EMJ. 2022; DOI/10.33590/emj/21-00148. https://dx.doi.org/10.33590/emj/21-00148.

7. Чазова И.Е., Шестакова М.В., Жернакова Ю.В. с соавт. Евразийские рекомендации по профилактике и лечению сердечно-сосудистых заболеваний у больных с диабетом и предиабетом (2021). Евразийский кардиологический журнал. 2021; (2): 6–61. [Chazova I.E., Shestakova M.V., Zhernakova Yu.V. et al. Eurasian Guidelines for the prevention and treatment of cardiovascular diseases in patients with diabetes and prediabetes (2021). Yevraziyskiy kardiologicheskiy zhurnal = Eurasian Heart Journal. 2021; (2): 6–61 (In Russ.)]. https://dx.doi.org/10.38109/2225-1685-2021-2-6-61. EDN: WAJGYZ.

8. American Diabetes Association. 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes – 2019. Diabetes Care. 2019; 42(Suppl 1): S13–S28. https://dx.doi.org/10.2337/dc19-S002.

9. International Expert Committee. International Expert Committee report on the role of the HbA1c assay in the diagnosis of diabetes. Diabetes Care. 2009; 32(7): 1327–34. https://dx.doi.org/10.2337/dc09-9033.

10. Barry E., Roberts S., Oke J. et al. Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: Systematic review and meta-analysis of screening tests and interventions. BMJ. 2017; 356: i6538. https://dx.doi.org/10.1136/bmj.i6538.

11. Pinelli N.R., Jantz A.S., Martin E.T., Jaber L.A. Sensitivity and specificity of glycated hemoglobin as a diagnostic test for diabetes and prediabetes in Arabs. J Clin Endocrinol Metab. 2011; 96(10): E1680–83. https://dx.doi.org/10.1210/jc.2011-1148.

12. Lee C.M.Y., Colagiuri S., Woodward M. et al. Comparing different definitions of prediabetes with subsequent risk of diabetes: An individual participant data meta-analysis involving 76 513 individuals and 8208 cases of incident diabetes. BMJ Open Diabetes Res Care. 2019; 7(1): e000794. https://dx.doi.org/10.1136/bmjdrc-2019-000794.

13. Kim G.S., Oh H.H., Kim S.H. et al. Association between prediabetes (defined by HbA1(C), fasting plasma glucose, and impaired glucose tolerance) and the development of chronic kidney disease: A 9-year prospective cohort study. BMC Nephrol. 2019; 20(1): 130.https://dx.doi.org/10.1186/s12882-019-1307-0.

14. Cai X., Zhang Y., Li M. et al. Association between prediabetes and risk of all cause mortality and cardiovascular disease: Updated meta-analysis. BMJ. 2020; 370: m2297. https://dx.doi.org/10.1136/bmj.m2297.

15. Cui K., Yin D., Song W. et al. The prognostic effect of prediabetes defined by different criteria in patients with stable coronary artery disease: A prospective cohort study in Asia. Eur J Prev Cardiol. 2023; 30(14): 1418–26. https://dx.doi.org/10.1093/eurjpc/zwad095.

16. European Medical Journal. EASD 2023: Study suggests re-evaluation of type 2 diabetes diagnosis criteria for women under 50. URL: https://www.emjreviews.com/diabetes/news/easd-2023-study-suggests-re-evaluation-of-type-2-diabetes-diagnosis-criteria-for-women-under-50/ (date of access – 01.11.2023).

17. Tabak A.G., Jokela M., Akbaraly T.N. et al. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet. 2009; 373(9682): 2215–21. https://dx.doi.org/10.1016/S0140-6736(09)60619-X.

18. Selvin E., Lazo M., Chen Y. et al. Diabetes mellitus, prediabetes, and incidence of subclinical myocardial damage. Circulation. 2014; 130(16): 1374–82. https://dx.doi.org/10.1161/CIRCULATIONAHA.114.010815.

19. Kristensen S.L., Jhund P.S., Lee M.M.Y. et al.; CHARM Investigators and Committees. Prevalence of prediabetes and undiagnosed diabetes in patients with HFpEF and HFrEF and associated clinical outcomes. Cardiovasc Drugs Ther. 2017; 31(5–6): 545–49.https://dx.doi.org/10.1007/s10557-017-6754-x.

20. Sasaki N., Ozono R., Maeda R. et al. Risk of hypertension in middle-aged and elderly participants with newly diagnosed type 2 diabetes and prediabetes. BMJ Open Diabetes Res Care. 2020; 8(1): e001500. https://dx.doi.org/10.1136/bmjdrc-2020-001500.

21. Richter B., Hemmingsen B., Metzendorf M.I., Takwoingi Y. Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia. Cochrane Database Syst Rev. 2018; 10(10): CD012661. https://dx.doi.org/10.1002/14651858.CD012661.pub2.

22. Esser N., Utzschneider K.M., Kahn S.E. Early beta cell dysfunction vs insulin hypersecretion as the primary event in the pathogenesis of dysglycaemia. Diabetologia. 2020; 63(10): 2007–21. https://dx.doi.org/10.1007/s00125-020-05245-x.

23. Kabadi U.M. Major pathophysiology in prediabetes and type 2 Diabetes: Decreased insulin in lean and insulin resistance in obese.J Endocr Soc. 2017; 1(6): 742–50. https://dx.doi.org/10.1210/js.2016-1116.

24. Демидова Т.Ю., Плахотняя В.М. Предиабет: фактор риска сердечно-сосудистых заболеваний и «окно возможностей» для их профилактики. FOCUS Эндокринология. 2023; 4(2): 6–11. [Demidova T.Yu., Plakhotnyaya V.M. Prediabetes: A risk factor for cardiovascular diseases and a window of opportunity for their prevention. FOCUS Endokrinologiya = FOCUS Endocrinology. 2023; 4(2): 6–11 (In Russ.)]. https://dx.doi.org/10.15829/2713-0177-2023-24. EDN: OSKPXC.

25. Brannick B., Dagogo-Jack S. Prediabetes and cardiovascular disease: Pathophysiology and interventions for prevention and risk reduction. Endocrinol Metab Clin North Am. 2018; 47(1): 33–50. https://dx.doi.org/10.1016/j.ecl.2017.10.001.

26. Mahat R.K., Singh N., Arora M., Rathore V. Health risks and interventions in prediabetes: A review. Diabetes Metab Syndr. 2019; 13(4): 2803–11. https://dx.doi.org/10.1016/j.dsx.2019.07.041.

27. Ryu H., Moon J., Jung J. Influence of health behaviors and occupational stress on prediabetic state among male office workers. Int J Environ Res Public Health. 2018; 15(6): 1264. https://dx.doi.org/10.3390/ijerph15061264.

28. Haring H.U. Novel phenotypes of prediabetes? Diabetologia. 2016; 59(9): 1806–18. https://dx.doi.org/10.1007/s00125-016-4015-3.

29. Драпкина О.М., Дроздова Л.Ю., Шепель Р.Н. с соавт. Анализ распространенности предиабета и реальная клиническая практика назначения медикаментозной терапии пациентам с предиабетом. Профилактическая медицина. 2022; 25(12): 96–105. [Drapkina O.M., Drozdova L.Yu., Shepel R.N. et al. Analysis of prediabetes prevalence and real-world practice in prescribing drug therapy to prediabetic patients. Profilakticheskaya meditsina = The Russian Journal of Preventive Medicine. 2022; 25(12): 96–105 (In Russ.)]. https://dx.doi.org/10.17116/profmed20222512196. EDN: DMEKXC.

30. Lindstrom J., Tuomilehto J. The Diabetes Risk Score: A practical tool to predict type 2 diabetes risk. Diabetes Care. 2003; 26(3): 725–31. https://dx.doi.org/10.2337/diacare.26.3.725.

31. Public Health Agency of Canada. The Canadian diabetes risk questionnaire CANRISK. URL: http://www.healthycanadians.gc.ca/diseases-conditions-maladies-affections/disease-maladie/diabetes-diabete/canrisk/index-eng.php (date of access – 01.11.2023).

32. ADA Classification and diagnosis of diabetes: Standards of medical care in diabetes – 2021. Diabetes Care. 2021; 44(Suppl. 1): S15–S33. https://dx.doi.org/10.2337/dc21-S002.

33. American Diabetes Association. Tools and calculators. Take the type 2 risk test. URL:https://diabetes.org/diabetes-risk-test (date of access – 01.11.2023).

34. Шестакова М.В., Колбин А.С., Галстян Г.Р. с соавт. «ДИАРИСК» – первый отечественный калькулятор риска предиабета и сахарного диабета 2 типа. Сахарный диабет. 2020; 23(5):404–411. [Shestakova M.V., Kolbin A.S., Galstyan G.R. et al. DIARISK – the first national prediabetes and diabetes mellitus type 2 risk calculator. Sakharnyy diabet = Diabetes Mellitus. 2020; 23(5): 404–411 (In Russ.)]. https://dx.doi.org/10.14341/DM12570. EDN: FFKKRK.

35. Wagner R., Heni M., Tabak A.G. et al. Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes. Nat Med. 2021; 27(1): 49–57. https://dx.doi.org/10.1038/s41591-020-1116-9.

36. Ларина В.Н. Глюкометрия и навыки самоконтроля как необходимые составляющие при ведении пациента с предиабетом в клинической практике врача-терапевта амбулаторного звена. FOCUS Эндокринология. 2023; 4(1): 23–30. [Larina V.N. Glucometry and self-control skills as necessary components in the management of a patient with prediabetes in the outpatient settings. FOCUS Endokrinologiya = FOCUS Endocrinology. 2023; 4(1): 23–30 (In Russ.)]. https://dx.doi.org/10.15829/2713-0177-2023-18. EDN: QJRFKS.

37. Dagogo-Jack S., Brewer A.A., Owei I. et al Pathobiology and Reversibility of Prediabetes in a Biracial Cohort (PROP-ABC) study: Design of lifestyle intervention. BMJ Open Diabetes Res Care. 2020; 8(1): e000899. https://dx.doi.org/10.1136/bmjdrc-2019-000899.